ישראל - עברית - Ministry of Health

bristol, myers squibb (israel) limited, israel - nivolumab; relatlimab - תרכיז להכנת תמיסה לאינפוזיה - relatlimab 4 mg/ml; nivolumab 12 mg/ml - nivolumab

ישראל - עברית - Ministry of Health

bristol, myers squibb (israel) limited, israel - mavacamten - קפסולות - mavacamten 10 mg - mavacamten

ישראל - עברית - Ministry of Health

bristol, myers squibb (israel) limited, israel - mavacamten - קפסולות - mavacamten 15 mg - mavacamten

ישראל - עברית - Ministry of Health

bristol, myers squibb (israel) limited, israel - mavacamten - קפסולות - mavacamten 2.5 mg - mavacamten

ישראל - עברית - Ministry of Health

bristol, myers squibb (israel) limited, israel - mavacamten - קפסולות - mavacamten 5 mg - mavacamten

ישראל - עברית - Ministry of Health

bristol, myers squibb (israel) limited, israel - deucravacitinib - טבליות מצופות פילם - deucravacitinib 6 mg - deucravacitinib

ישראל - עברית - Ministry of Health

bristol, myers squibb (israel) limited - atazanavir as sulfate 150 mg - capsules - atazanavir - reyataz is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.

ישראל - עברית - Ministry of Health

bristol - myers squibb, israel - entecavir; entecavir - טבליות מצופות פילם - entecavir 0.5 mg; entecavir 0.5 mg - entecavir - entecavir - baraclude is indicated for the treatment of chronic hepatitis b virus (hbv) infection in adults with compensated liver disease and evidence of active viral replication, and persistently elevated serum alanine aminotransferase (alt) levels. this indication is based on clinical trial data in patients with hbeag positive and hbeag negative hbv infection, nucleoside naive patients and patients with lamivudine-refractory hepatitis b.decompensated liver disease.

ישראל - עברית - Ministry of Health

bristol, myers squibb (israel) limited - entecavir 1 mg - film coated tablets - entecavir - baraclude is indicated for the treatment of chronic hepatitis b virus (hbv) infection in adults with compensated liver disease and evidence of active viral replication, and persistently elevated serum alanine aminotransferase (alt) levels. this indication is based on clinical trial data in patients with hbeag positive and hbeag negative hbv infection, nucleoside naive patients and patients with lamivudine-refractory hepatitis b.decompensated liver disease.

ישראל - עברית - Ministry of Health

bristol, myers squibb (israel) limited, israel - ipilimumab - תרכיז להכנת תמיסה לאינפוזיה - ipilimumab 5 mg/ml - ipilimumab - ipilimumab - yervoy (ipilimumab) is indicated for the treatment of unresectable or metastatic melanoma.